NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Response to ASX Query - Appendix 4C , page-10

  1. 3,083 Posts.
    lightbulb Created with Sketch. 46
    The other negotiations relate to the development of NNZ-2566 through Phase 2 trials and
    BEYOND. In this regard new investment is being sought to compliment the previously
    announced US Army funding. These negotiations are ongoing and have taken longer than
    indicated in our response to you dated 17 April 2009, however the Company believes that
    once these negotiations are concluded IT WILL, in conjunction with US Army funding for the
    NNZ-2566 Phase 2 trial, have funding available more than two quarters of activities


    1: They are not negotiating...but in negotiations outlined in ANSWER2 for cap raising and licensing.

    2:I like the term BEYOND the phase2 trails so maybe a deal to take nnz2566 through to the end this could be worth big dollars.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.